Precision Antibody
Precision Antibody is a leading provider of custom antibody development services, with over 24 years of experience and more than 20,000 successful projects delivered to over 500 organizations worldwide. The company specializes in rapid, high-quality, application-specific monoclonal and polyclonal antibody development, production, and characterization, serving pharmaceutical, biotech, academic, and government clients. Precision Antibody is recognized for its proprietary technologies, award-winning services, and a success rate exceeding 95% in delivering antibodies that perform as intended. Accredited by AAALAC and OLAW, the company is committed to strict quality control, confidentiality, and milestone-based, transparent pricing. Their mission is to enable scientific advancement through innovative, reliable, and tailored antibody solutions.
Industries
Nr. of Employees
small (1-50)
Precision Antibody
9130 Red Branch Road, Suite X, Columbia, MD 21045
Products
Anti-HRP2 monoclonal antibodies (multiple clones and sample packs)
Panels and individual mouse monoclonal antibodies targeting Plasmodium falciparum histidine-rich protein 2 (HRP2) supplied in liquid or lyophilized formats; validated for ELISA and suitable for malaria diagnostic development.
Anti-COV-2 and anti-SARS-CoV-2 antigen monoclonal antibodies (neutralizing, S1 RBD and nucleocapsid)
Panels of mouse monoclonal antibodies against SARS-CoV-2 antigens including neutralizing antibodies, S1 RBD binders and nucleocapsid-specific clones; supplied as purified antibody with validation for common detection platforms.
Anti-AR-V7, Anti-MAP1S, Anti-MYC and other oncology research antibodies
Individual mouse monoclonal antibodies directed to oncology- and research-related targets, supplied purified or lyophilized and validated for applications such as Western blot and IHC.
GP88 / Progranulin recombinant human protein
Recombinant human GP88/Progranulin protein provided at defined concentration and purity for use as assay reagent or control material; shipping and storage conditions specified.
GP88 / Progranulin IHC control slides
Formalin-fixed paraffin-embedded positive and negative control slide sets for Progranulin IHC assay validation and pathology QC.
Anti-HRP2 monoclonal antibodies (multiple clones and sample packs)
Panels and individual mouse monoclonal antibodies targeting Plasmodium falciparum histidine-rich protein 2 (HRP2) supplied in liquid or lyophilized formats; validated for ELISA and suitable for malaria diagnostic development.
Anti-COV-2 and anti-SARS-CoV-2 antigen monoclonal antibodies (neutralizing, S1 RBD and nucleocapsid)
Panels of mouse monoclonal antibodies against SARS-CoV-2 antigens including neutralizing antibodies, S1 RBD binders and nucleocapsid-specific clones; supplied as purified antibody with validation for common detection platforms.
Anti-AR-V7, Anti-MAP1S, Anti-MYC and other oncology research antibodies
Individual mouse monoclonal antibodies directed to oncology- and research-related targets, supplied purified or lyophilized and validated for applications such as Western blot and IHC.
GP88 / Progranulin recombinant human protein
Recombinant human GP88/Progranulin protein provided at defined concentration and purity for use as assay reagent or control material; shipping and storage conditions specified.
GP88 / Progranulin IHC control slides
Formalin-fixed paraffin-embedded positive and negative control slide sets for Progranulin IHC assay validation and pathology QC.
Services
Project-based development of monoclonal and polyclonal antibodies across species and formats, tailored for the target application and delivered as clones, supernatants, purified antibodies or sequence data.
Milligram-to-gram scale production and affinity purification from hybridomas, production cell lines or transient expression systems, with buffer exchange, concentration control and analytical release documentation.
Biophysical and biochemical characterization including label-free kinetic analysis, epitope binning and application compatibility testing to support assay or therapeutic selection.
Custom in vitro and in vivo assays to evaluate antibody functional performance, including neutralization assays, receptor internalization, flow assays, IHC and custom enzyme immunoassays.
Supplemental services including variable-region sequencing, antibody humanization, cell bank generation, conjugation, isoelectric point measurement, analytical SEC, stability testing and epitope mapping.
Design and provision of sandwich ELISA kits and associated reagents for biomarker measurement and clinical study support.
Project-based development of monoclonal and polyclonal antibodies across species and formats, tailored for the target application and delivered as clones, supernatants, purified antibodies or sequence data.
Milligram-to-gram scale production and affinity purification from hybridomas, production cell lines or transient expression systems, with buffer exchange, concentration control and analytical release documentation.
Biophysical and biochemical characterization including label-free kinetic analysis, epitope binning and application compatibility testing to support assay or therapeutic selection.
Custom in vitro and in vivo assays to evaluate antibody functional performance, including neutralization assays, receptor internalization, flow assays, IHC and custom enzyme immunoassays.
Supplemental services including variable-region sequencing, antibody humanization, cell bank generation, conjugation, isoelectric point measurement, analytical SEC, stability testing and epitope mapping.
Design and provision of sandwich ELISA kits and associated reagents for biomarker measurement and clinical study support.
Expertise Areas
- Custom antibody development (monoclonal and polyclonal)
- Fully human monoclonal antibody discovery using trans-chromosomic animal models
- Antigen design and accelerated immunization strategies
- Hybridoma technology and single-cell cloning
Key Technologies
- Hybridoma generation and single-cell cloning
- Trans-chromosomic animals carrying human immunoglobulin loci
- Biolayer interferometry
- Surface plasmon resonance
News & Updates
Dr. Ginette Serrero, CEO of A&G Pharmaceutical Inc., DBA Precision Antibody, presented two posters at the American Association of Cancer Research’s annual meeting.
Explores how mammalian cell banks reduce risks, ensure compliance, and support success in biopharma production.
Discusses when and why preclinical programs should consider engineered antibodies for optimal results.
Describes how functional assays can predict clinical trial outcomes and boost regulatory confidence.
Explains the importance of screening and characterization in ensuring efficacy and accelerating drug success.
Highlights the growing importance of rigorous antibody characterization in biomedical research.
Dr. Ginette Serrero, CEO of A&G Pharmaceutical Inc., DBA Precision Antibody, presented two posters at the American Association of Cancer Research’s annual meeting.
Explores how mammalian cell banks reduce risks, ensure compliance, and support success in biopharma production.
Discusses when and why preclinical programs should consider engineered antibodies for optimal results.
Describes how functional assays can predict clinical trial outcomes and boost regulatory confidence.
Explains the importance of screening and characterization in ensuring efficacy and accelerating drug success.
Highlights the growing importance of rigorous antibody characterization in biomedical research.